ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $288,000 | +17.6% | 10,000 | +29.9% | 0.01% | +40.0% |
| Q3 2016 | $245,000 | -73.3% | 7,701 | -76.5% | 0.01% | -70.6% |
| Q1 2016 | $917,000 | -64.2% | 32,770 | -54.4% | 0.02% | -34.6% |
| Q4 2015 | $2,564,000 | +97.2% | 71,920 | +82.9% | 0.03% | +116.7% |
| Q3 2015 | $1,300,000 | +150.5% | 39,319 | +217.5% | 0.01% | +140.0% |
| Q2 2015 | $519,000 | -50.9% | 12,383 | -61.8% | 0.01% | -50.0% |
| Q1 2015 | $1,058,000 | -61.1% | 32,450 | -62.1% | 0.01% | -41.2% |
| Q4 2014 | $2,718,000 | +62.1% | 85,586 | +26.4% | 0.02% | +88.9% |
| Q3 2014 | $1,677,000 | +81.9% | 67,694 | +65.9% | 0.01% | +125.0% |
| Q2 2014 | $922,000 | -31.0% | 40,800 | -25.7% | 0.00% | -42.9% |
| Q1 2014 | $1,336,000 | -46.2% | 54,905 | -44.8% | 0.01% | -46.2% |
| Q4 2013 | $2,483,000 | -29.2% | 99,383 | -22.2% | 0.01% | -38.1% |
| Q3 2013 | $3,508,000 | +12.1% | 127,727 | -25.9% | 0.02% | +10.5% |
| Q2 2013 | $3,130,000 | – | 172,457 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |